We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Daily Aspirin Risks May Outweigh Benefits

By HospiMedica International staff writers
Posted on 14 Jan 2014
Healthy adults who take aspirin daily to ward off potential heart disease may suffer more harm than good, according to a new review of studies.

Researchers at the University of Warwick (Coventry, United Kingdom) reviewed data sources that included ten electronic bibliographic databases, contact with experts, and scrutiny of the reference lists of included past studies, with eligible studies restricted to publications from 2008 to 2012. More...
They then used novel methods to reevaluate the balance of benefits and harms of using preventive aspirin. The researchers found that of 2,572 potentially relevant papers, just 27 met the inclusion criteria.

The results showed that regular aspirin intake resulted in the successful avoidance 60–84 major cardiovascular disease (CVD) events and 34–36 colorectal cancer deaths per 100,000 person-years. However, in the same time span, 46–49 major bleeds and 68–117 gastrointestinal bleeds in 10,000 people in a 10-year period also occurred. This translates to a 37% increased risk of stomach bleeding and a 38% increase in the risk of hemorrhagic stroke. The study was published on December 5, 2013, in PLoS One.

“We have found that the benefit from regular aspirin use in primary prevention of CVD is modest, while its use increases risk of hemorrhagic stroke and major and minor bleeding,” concluded lead author Paul Sutcliffe, MD, and colleagues of Warwick Medical School. “We need to be extremely careful about promoting the daily use without fully understanding all the evidence.”

“The risks are finely balanced and for now there is not the evidence to advise people to take it. It would be lovely to say over-50’s should take an aspirin a day and have much less cancer, but the research hasn't yet been done and we should be cautious,” added corresponding author Aileen Clarke, MD. “We need to be extremely careful about over-promoting aspirin.”

Aspirin has an antiplatelet effect by inhibiting the production of thromboxane, which under normal circumstances binds platelet molecules together to create a patch over damaged walls of blood vessels. Because the platelet patch can grow large enough to block blood flow—both locally and downstream—aspirin is also used long-term, at low doses, to help prevent heart attacks, strokes, and blood clot formation in people at high risk of thrombosis. Aspirin may be also be effective at preventing certain types of cancer, particularly colorectal cancer.

Related Links:

University of Warwick



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
PACS Workstation
PaxeraView PRO
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.